Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions. Rooting to Freyr’s outbound reach, the Italy-based pharma company joined multiple discussions with Freyr on varied requirements and took note of the Regulatory provider’s strong knowledge base, team structures, and cost-effective solutions. Eventually, the discussions awarded Freyr a project regarding NDA/MAA submissions. At the outset, given the customer’s willingness to outsource Regulatory requirements itself is a big achievement for Freyr. Because they had historically proven to be unwilling to outsource their requirements.
Their decision demonstrated how trust Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions. Rooting to Freyr’s outbound reach, the Italy-based pharma company joined multiple discussions with Freyr on varied requirements and took note of the Regulatory
provider’s strong
NDA/MAA submissions, Regulatory support, Regulatory. Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, supporting large, medium, and small size global life sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post-approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions. Freyr is also expanding its footprint into other key areas like Pharmacovigilance. Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore,
Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions. Rooting to Freyr’s outbound reach, the Italy-based pharma company joined multiple discussions with Freyr on varied requirements and took note of the Regulatory provider’s strong knowledge base, team structures, and cost-effective solutions. Eventually, the discussions awarded Freyr a project regarding NDA/MAA submissions. At the outset, given the customer’s willingness to outsource Regulatory requirements itself is a big achievement for Freyr. Because they had historically proven to be unwilling to outsource their requirements. Their decision demonstrated how trust Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions. Rooting to Freyr’s outbound reach, the Italy-based pharma company joined multiple discussions with Freyr on varied requirements and took note of the Regulatory
provider’s strong
NDA/MAA submissions, Regulatory support, Regulatory. Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, supporting large, medium, and small size global life sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post-approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions. Freyr is also expanding its footprint into other key areas like Pharmacovigilance. Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, Japan, and a Global Delivery Center in Hyderabad, India. Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, Japan, and a Global Delivery Center in Hyderabad, India.
